Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial.

MLA

Pitchford, Lisa M., et al. “Safety, Tolerability, and Pharmacokinetics of Repeated Oral Doses of 2-Hydroxybenzylamine Acetate in Healthy Volunteers: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.” BMC Pharmacology & Toxicology, vol. 21, no. 1, Jan. 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s40360-020-0382-y.

APA

Pitchford, L. M., Driver, P. M., Fuller, J. C., Akers, W. S., Abumrad, N. N., Amarnath, V., Milne, G. L., Chen, S.-C., Ye, F., Roberts II, L. J., Shoemaker, M. B., Oates, J. A., Rathmacher, J. A., & Boutaud, O. (2020). Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial. BMC Pharmacology & Toxicology, 21(1), 1–10. https://doi.org/10.1186/s40360-020-0382-y

Chicago

Pitchford, Lisa M., Patricia M. Driver, John C. Fuller, Wendell S. Akers, Naji N. Abumrad, Venkataraman Amarnath, Ginger L. Milne, et al. 2020. “Safety, Tolerability, and Pharmacokinetics of Repeated Oral Doses of 2-Hydroxybenzylamine Acetate in Healthy Volunteers: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.” BMC Pharmacology & Toxicology 21 (1): 1–10. doi:10.1186/s40360-020-0382-y.